Evidence map›Paper›PMID 33804404›Full record

ArticleInternational journal of molecular sciences2021

Plasma Proteomic Profiling in Hypertrophic Cardiomyopathy Patients before and after Surgical Myectomy Reveals Post-Procedural Reduction in Systemic Inflammation.

Amy Larson, Towia A Libermann, Heather Bowditch, Gaurav Das, Nikolaos Diakos, Gordon S Huggins, Hassan Rastegar, Frederick Y Chen, Ethan J Rowin, Martin S Maron and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Genetic and Molecular Mechanisms of Hypertrophic Cardiomyopathy.International journal of molecular sciences · 2023
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Amy LarsonMolecular Cardiology Research Institute, Tufts Medical Center, Boston, MA 02111, USA.ORCID 0000-0002-5217-3347
Towia A LibermannGenomics, Proteomics, Bioinformatics and Systems Biology Center, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0002-4006-8179
Heather BowditchMolecular Cardiology Research Institute, Tufts Medical Center, Boston, MA 02111, USA.
Gaurav DasMolecular Cardiology Research Institute, Tufts Medical Center, Boston, MA 02111, USA.
Nikolaos DiakosCardioVascular Center, Tufts Medical Center, Boston, MA 02111, USA.
Gordon S HugginsMolecular Cardiology Research Institute, Tufts Medical Center, Boston, MA 02111, USA.
Hassan RastegarCardioVascular Center, Tufts Medical Center, Boston, MA 02111, USA.
Frederick Y ChenCardioVascular Center, Tufts Medical Center, Boston, MA 02111, USA.
Ethan J RowinCardioVascular Center, Tufts Medical Center, Boston, MA 02111, USA.
Martin S MaronCardioVascular Center, Tufts Medical Center, Boston, MA 02111, USA.
Michael T ChinMolecular Cardiology Research Institute, Tufts Medical Center, Boston, MA 02111, USA.ORCID 0000-0003-3065-8498
Tufts Medical Center · USBeth Israel Deaconess Medical Center · US

Funding

Tufts Clinical and Translational Science Institute (Pilot Supplement)UL1TR002544 · NCATS · TUFTS UNIVERSITY BOSTON · PI SELKER, HARRY P. · 2018 to 2022
$50.2M
Characterization of Pathological Pathways of Hypertrophic Cardiomyopathy at Single Cell ResolutionF32HL147492 · NHLBI · TUFTS MEDICAL CENTER · PI GORDON, AMY LARSON · 2020 to 2020
$32k
American Heart Association 18IPA34170294NCATS NIH HHS UL1 TR002544NIH HHS F32HL147492NIH HHS UL1TR002544
6 · The paper itself

Abstract

Left Ventricular Outflow Tract (LVOT) obstruction occurs in approximately 70% of Hypertrophic Cardiomyopathy (HCM) patients and currently requires imaging or invasive testing for diagnosis, sometimes in conjunction with provocative physiological or pharmaceutical stimuli. To identify potential biomarkers of LVOT obstruction, we performed proteomics profiling of 1305 plasma proteins in 12 HCM patients with documented LVOT obstruction, referred for surgical myectomy. Plasma was collected at the surgical preoperative visit, approximately one month prior to surgery and then at the post-surgical visit, approximately 3 months later. Proteomic profiles were generated using the aptamer-based SOMAscan assay. Principal Component Analysis using the highest statistically significant proteins separated all preoperative samples from all postoperative samples. Further analysis revealed a set of 25 proteins that distinguished the preoperative and postoperative states with a paired

Indexed as

AdultAgedBiomarkersCardiac Surgical ProceduresCardiomyopathy, HypertrophicFemaleHumansInflammationMaleMiddle AgedProteomeBiomarkersProteomeaptamercardiovascular diseasehypertrophic cardiomyopathymyectomy surgeryproteomics

Identifiers

PMID33804404
PMCPMC7957543
OpenAlexW3133533461

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.